Naproxen
Product Images NDC 53217-262

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Naproxen (NDC 53217-262). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Naproxen 375 Usp 1)

Chemical structure diagram of Naproxen and Naproxen sodium. The image shows the molecular formulas C14H14O3 for Naproxen and C14H13NaO3 for Naproxen sodium, with molecular weights 230.26 and 252.23 respectively. It highlights the structural difference at the R group position (COOH for Naproxen, COONa for Naproxen sodium).*

FDA Label Image

Image Description (Naproxen 375 Usp 2)

Naproxen USP 375 mg tablet label featuring 30 tablets per package. The label highlights the active ingredient as Naproxen USP 375 mg, describes the tablet as a light orange oval with markings on one side and the dosage on the reverse. It is labeled as generic for Naprosyn, packaged by Aidarex Pharmaceuticals LLC with manufacturing by Glenmark Pharmaceuticals Ltd., India. The label also includes the NDC 53217-0262-30 and space for lot number and instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.